基质金属蛋白酶-1,matrix metalloproteinase-1
1)matrix metalloproteinase-1基质金属蛋白酶-1
1.Relationship between matrix metalloproteinase-1 polymorphism and coronary heart disease in Han population in Yunnan;云南汉族人基质金属蛋白酶-1基因多态性与冠心病的相关性
2.Relationship of expression on collagen type Ⅲ and matrix metalloproteinase-1 in Congenital muscular torticollis;肌性斜颈中基质金属蛋白酶-1与Ⅲ型胶原的表达关系
3.Relationship between level of matrix metalloproteinase-1 and risk stratification in the patients with unstable angina;基质金属蛋白酶-1水平与不稳定性心绞痛危险度分层的关系
英文短句/例句

1.Expression of Matrix Metalloproteinase-1 (MMP-1) and MMP-2 in Endometriotic Tissues;基质金属蛋白酶-1、-2在异位内膜组织中的表达
2.The role of membrane-type 1 matrix metalloproteinase in tumor膜型基质金属蛋白酶-1在肿瘤中的作用
3.Effect of orthodontic force on the expression of MMP-1 and TIMP-1 in gingival crevicular fluid of human正畸力作用下基质金属蛋白酶-1及金属蛋白酶组织抑制因子-1在龈沟液中的表达
4.Analysis of the Relation of IL-1、MMP-13 with Osteoarthritis;白细胞介素-1、基质金属蛋白酶-13含量与骨性关节炎的关系
5.Expression and Significance of MMP-1、MMP-3 on Lens Epithelial Cells(LECs) of Human Age-related Cataract;基质金属蛋白酶-1、3在白内障患者晶状体上皮细胞的表达及意义
6.A Study of the Relationship between Lung Cancer Sensitivity and Gene Polymorphisms of MMP-1,-9基质金属蛋白酶-1,-9基因多态性和肺癌易感性关系的研究
7.A Study of Relation between Matrix Metalloproteinas e-1 Polymorphism and Coronary Heart Disease in Han Population of Yunnan.;云南汉族人基质金属蛋白酶-1基因多态性与冠心病的相关性研究
8.Expressions of ColⅠ, ColⅣ, MMP-1, and MMP-2 in oral squamous cell carcinoma口腔鳞癌中Ⅰ、Ⅳ型胶原及基质金属蛋白酶-1、2的表达及意义
9.The Study on the Expression of MT1-MMP in Keratoconus;膜型基质金属蛋白酶-1(MT1-MMP)在圆锥角膜中表达的研究
10.The Relation between Coronary Heart Disease and Matrix Metalloproteinase-9、Tissue Inhibitors of Matris Metalloproteinase-1;冠心病与基质金属蛋白酶-9、基质金属蛋白酶抑制因子-1的关系
11.Effect of Mycophenolate Mofetil on Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-1 in Diabetic Rats Renal Tissues;霉酚酸酯对糖尿病大鼠肾脏基质金属蛋白酶-9及基质金属蛋白酶抑制剂-1的调控研究
12.The Expression and Significance of Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis;基质金属蛋白酶-9及基质金属蛋白酶组织抑制剂-1在子宫内膜异位症中的表达及意义
13.Relationship between Matrix Metalloproteinase-9/Tissue Inhibitor-1 of Metalloproteinases and Ventricular Remodeling after Acute Myocardial Infarction基质金属蛋白酶9及基质金属蛋白酶抑制因子1与急性心肌梗死后心室重构
14.The relationship between the expression of MMP-9,its inhibitor TIMP-1 and angiogenesis in invasive ovarian epithelial carcinoma基质金属蛋白酶-9及基质金属蛋白酶组织抑制物-1与卵巢上皮性癌血管生成的关系
15.Expression of CAV-1 and MMP-2 in bladder cancer and the relationship between them小窝蛋白-1、基质金属蛋白酶-2在膀胱癌的表达及其关系
16.Expression of Caveolin-1 and MMP-2 and Its Relation in Bladder Cancer;小窝蛋白-1和基质金属蛋白酶-2在膀胱癌中的表达及其关系
17.Clinical significance of anti-β2 glycoprotein 1 antibody and matrix metalloproteinase-9 and their association with Kawasaki disease抗β_2糖蛋白1抗体、基质金属蛋白酶9与川崎病相关性及临床意义
18.Clinical Significance of Expression of Matix Metalloproteinase-9、3 and Tissue Inhibitor of Metalloproteinase-1 in Glomeruli of Membranous Nephropathy;基质金属蛋白酶-9、3和金属蛋白酶组织抑制物-1在膜性肾病肾小球中的表达及意义
相关短句/例句

MMP-1基质金属蛋白酶-1
1.Expressions of ColⅠ, ColⅣ, MMP-1, and MMP-2 in oral squamous cell carcinoma;口腔鳞癌中Ⅰ、Ⅳ型胶原及基质金属蛋白酶-1、2的表达及意义
2.Investigation of the role of IL-1 and MMP-1 on the pathogenesis of knee osteoarthritis;白细胞介素-1、基质金属蛋白酶-1在膝关节骨性关节炎发病中的作用探讨
3.The Effect of Homocysteine on MMP-1 Secreted by Vascular Smooth Muscle Cells;同型半胱氨酸对血管平滑肌细胞基质金属蛋白酶-1的影响
3)Matrix metalloproteinases-1基质金属蛋白酶-1
4)matrix metalloproteinase-1 (MMP-1)基质金属蛋白酶-1(MMP-1)
5)MMP1 gene基质金属蛋白酶1基因
6)Mattrix metalloproteinase基质金属蛋白酶-1基因
延伸阅读

结晶胰蛋白酶 ,胰蛋白酶药物名称:结晶胰蛋白酶英文名:Trypsin别名: 结晶胰蛋白酶 ,胰蛋白酶外文名:Trypsin 适应症: 1.用于脓胸、血胸、外科炎症、溃疡、创伤性损伤、娄管等所产生的局部水肿、血肿、脓肿。 2.用于呼吸道疾病。 3.用于治疗毒蛇咬伤,曾试用于竹叶青、银环蛇、眼镜蛇、蝮蛇等毒蛇咬伤的各型病人800余例,均获治愈。 用量用法: 1.一般应用:1次5000单位,每日1次肌注,用量酌情而定。为防止疼痛,可加适量普鲁卡因。局部用药视情而定,可配成溶液制剂(pH7.4~8.2,微碱性时活性最强)、喷雾剂、粉剂、油膏等,用作体腔内注射、患部注射、喷雾、湿敷、涂搽等。 2.治蛇毒:取注射用结晶胰蛋白酶2000单位1~3支,加0.25%~0.5%盐酸普鲁卡因(或注射用水)4~20ml稀释,以牙痕为中心,在伤口周围作浸润注射,或在肿胀部位上方作环状封闭1~2次。如病情需要可重复使用。若伤肢肿胀明显,可于注射本品30分钟后,切开伤口排毒减压(严重出血者例外),也可在肿胀部位针刺排毒。如伤口已坏死、溃烂,可用其0.1%溶液湿敷患处 注意事项: 1.较常见的不良反应有寒战、发热、头痛、头晕、胸痛、腹痛等,但并不影响继续用药,一般给予抗组胺药和解热药,即可控制或预防。 2.不可用于急性炎症及出血空腔中。 3.肝肾损伤、血液凝固异常和有出血倾向的病人忌用。 4.吸取注射液后应另换针头,以免注射时疼痛。 5.不可作静注。用前需作划痕试验,应注意可能产生过敏反应。 6.外用时,可采用注射用制剂以缓冲液溶解,但必须在3小时内用毕。 规格: 注射用结晶胰蛋白酶:每支1000单位、2000单位、5000单位、10000单位.类别:酶类及生化药物